Aberrant ZNF423 impedes B cell differentiation and is linked to adverse outcome of ETV6-RUNX1 negative B precursor acute lymphoblastic leukemia
about
ZNF423 and ZNF521: EBF1 Antagonists of Potential Relevance in B-Lymphoid MalignanciesSomatic drivers of B-ALL in a model of ETV6-RUNX1; Pax5(+/-) leukemia.Ebf1 heterozygosity results in increased DNA damage in pro-B cells and their synergistic transformation by Pax5 haploinsufficiencyTranscriptional dysregulation of the multifunctional zinc finger factor 423 in acute lymphoblastic leukemia of childhoodPlacental transcriptome co-expression analysis reveals conserved regulatory programs across gestation.Influence of maternal obesity, diet and exercise on epigenetic regulation of adipocytes.The regulatory network of B-cell differentiation: a focused view of early B-cell factor 1 functionThe role of Pax5 in leukemia: diagnosis and prognosis significance.Transcription factor networks in B-cell differentiation link development to acute lymphoid leukemia.Potential therapeutic targets and small molecular drugs for pediatric B-precursor acute lymphoblastic leukemia treatment based on microarray dataZNF423: Transcriptional modulation in development and cancer.Expression profiling and functional implications of a set of zinc finger proteins, ZNF423, ZNF470, ZNF521, and ZNF780B, in primary osteoarthritic articular chondrocytes.Calmodulin-like protein 3 is an estrogen receptor alpha coregulator for gene expression and drug response in a SNP, estrogen, and SERM-dependent fashion.Epigenetic modifications of the Zfp/ZNF423 gene control murine adipogenic commitment and are dysregulated in human hypertrophic obesity.Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis.ZNF423: A New Player in Estrogen Receptor-Positive Breast Cancer.
P2860
Q26770729-AFF4F924-F51B-4989-B96C-54F061815492Q35744654-79D6678E-1222-40E8-9855-A74CED598C81Q35784511-9C00CBBC-2425-4470-948B-0FD9B01A32D7Q35951460-D0C42C21-F324-466B-982A-A6AA8AC6864CQ36238773-0325EE2A-68AF-4824-9A26-B532A36F2AEFQ37710116-DE9075B6-488C-42D7-8F27-DDDEE1E55C1DQ38239865-A412F77A-E9EF-4096-9F1B-483CAAD5A855Q38271843-F4FF1359-E8EB-47B4-BEDF-178DAF18C3E4Q38492313-30A39467-18AC-4641-9B52-304EB3CD4CC8Q38633676-CDE5854A-C87F-4E2D-9567-6765B46141D3Q38866728-3D611004-7744-4916-9E51-E1E9C00B4F0AQ38979783-EF2E8BE0-735E-4A30-A01F-8508187548FAQ41460767-146DD228-EC33-4693-B49E-EFE888BE9F5FQ42795840-794FBCCA-AF2F-47A7-AEE2-53641D0E9DFEQ47133341-7B0AE0F6-91E9-4280-B61E-6331D74BF1F1Q55385618-706DEE4A-E06F-479C-8631-289126AA6181
P2860
Aberrant ZNF423 impedes B cell differentiation and is linked to adverse outcome of ETV6-RUNX1 negative B precursor acute lymphoblastic leukemia
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aberrant ZNF423 impedes B cell ...... r acute lymphoblastic leukemia
@en
Aberrant ZNF423 impedes B cell ...... acute lymphoblastic leukemia.
@nl
type
label
Aberrant ZNF423 impedes B cell ...... r acute lymphoblastic leukemia
@en
Aberrant ZNF423 impedes B cell ...... acute lymphoblastic leukemia.
@nl
prefLabel
Aberrant ZNF423 impedes B cell ...... r acute lymphoblastic leukemia
@en
Aberrant ZNF423 impedes B cell ...... acute lymphoblastic leukemia.
@nl
P2093
P2860
P356
P1476
Aberrant ZNF423 impedes B cell ...... r acute lymphoblastic leukemia
@en
P2093
Anna-Sophie Behlich
Antonia Zech
Arne Hansen
Benjamin Otto
Bine Klingler
Carol Stocking
Elisabeth Kremmer
Georg Eschenburg
Kevin Dierck
Lena Harder
P2860
P304
P356
10.1084/JEM.20130497
P407
P577
2013-09-30T00:00:00Z